Your browser doesn't support javascript.
loading
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Park, Shinhee; Jo, Kyung-Wook; Lee, Sang Do; Kim, Woo Sung; Shim, Tae Sun.
Afiliação
  • Park S; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Jo KW; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Lee SD; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Kim WS; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Shim TS; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Electronic address: shimts@amc.seoul.kr.
Respir Med ; 131: 43-48, 2017 10.
Article em En | MEDLINE | ID: mdl-28947041

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Pulmonar / Tuberculose Resistente a Múltiplos Medicamentos / Antituberculosos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Pulmonar / Tuberculose Resistente a Múltiplos Medicamentos / Antituberculosos Idioma: En Ano de publicação: 2017 Tipo de documento: Article